Xiaoqian Ma

9PUBLICATIONS
12CO-AUTHORS
Animal protection (incl. pests and pathogens)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 17, 2026
Clinical Trial for Safety of Porcine Islet Xenotransplantation From PERV-C Free DPF Donor Piglets in Patients With Type 1 Diabetes.

|Feb 23, 2025
Targeted delivery of CCL3 reprograms macrophage antigen presentation and enhances the efficacy of immune checkpoint blockade therapy in hepatocellular carcinoma.

Muqi Liu, Linzhe Li, Lu Cao

|Jun 28, 2024
Establishment of a donor pig for xenotransplantation clinical trials based on the principle of Changsha Communiqué.

Xiaoqian Ma, Sang Li, Jia Wang

|Jan 16, 2023
CD27-Expressing Xenoantigen-Expanded Human Regulatory T Cells Are Efficient in Suppressing Xenogeneic Immune Response.

Lu Cao, Xiaoqian Ma, Juan Zhang

|May 27, 2020
Mouse Umbilical Cord Mesenchymal Stem Cell Paracrine Alleviates Renal Fibrosis in Diabetic Nephropathy by Reducing Myofibroblast Transdifferentiation and Cell Proliferation and Upregulating MMPs in Mesangial Cells.

Hongde Li, Pengfei Rong, Xiaoqian Ma

|Oct 04, 2019
Human mesenchymal stem cells-derived conditioned medium inhibits hypoxia-induced death of neonatal porcine islets by inducing autophagy.

Yuzhi Xu, Mengqun Tan, Xiaoqian Ma

Pageof 2

Frequent Collaborators

3 joint publications

Pengfei Rong

3 joint publications

Wei Wang

2 joint publications

Wei Nie

2 joint publications

Lu Cao